Effect of TachoSil in a coagulopathic pig model with blunt liver injuries

J Surg Res. 2011 Nov;171(1):234-9. doi: 10.1016/j.jss.2010.02.002. Epub 2010 Mar 4.

Abstract

Objective: In this study, we investigated the efficacy of a fibrinogen/thrombin-coated collagen patch (TachoSil) to terminate severe bleeding in a coagulopathic pig model with blunt liver injury.

Methods: Following surgical preparation, which included splenectomy and cystotomy, coagulopathy was induced by exchanging 80% of the animal's blood volume with hydroxyethylstarch 130/0.4 and lactated Ringer's solution. Subsequently, a grade III liver injury was induced by a force of 238 ± 19 Newton and free bleeding was allowed for 30 s. Animals were randomly assigned to receive either a placebo patch (cotton patch) (control group, n = 7) or a fibrinogen/thrombin patch (FT patch group, n = 7), which was positioned 30 s after injury on the inflicted area. Coagulation parameters, hemodynamic variables, as well as treatment were monitored for 2 h post-injury and patch placement. Histology was obtained to evaluate the equality of liver injury and to show the morphology of the FT patch.

Results: Hemostasis after hemodilution was severely impaired. Blood loss after trauma was significantly diminished in the FT patch group (419 mL ± 90 mL) compared with the control group (1775 mL ± 358 mL) (P < 0.001). All animals treated with the FT patch survived, whereas 100% of the control group died before reaching the end of the observation period (P < 0.001). Gross sectioning and histology showed an equal degree of injury with a tight adherence of the FT patch.

Conclusion: TachoSil under severe coagulopathy effectively controlled bleeding and successfully prevented hemorrhagic death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Cell Count
  • Blood Coagulation Disorders / chemically induced
  • Blood Coagulation Disorders / drug therapy*
  • Disease Models, Animal
  • Drug Combinations
  • Fibrinogen / pharmacology*
  • Hemodynamics
  • Hemorrhage / drug therapy*
  • Hemorrhage / etiology
  • Hydroxyethyl Starch Derivatives / pharmacology
  • Isotonic Solutions / pharmacology
  • Liver / injuries*
  • Male
  • Plasma Substitutes / pharmacology
  • Ringer's Lactate
  • Surgical Sponges*
  • Survival Rate
  • Sus scrofa
  • Thrombelastography / drug effects
  • Thrombin / pharmacology*
  • Wounds, Nonpenetrating / complications*

Substances

  • Drug Combinations
  • Hydroxyethyl Starch Derivatives
  • Isotonic Solutions
  • Plasma Substitutes
  • Ringer's Lactate
  • TachoSil
  • Fibrinogen
  • Thrombin